Seth Olson is an associate in the Washington, D.C. office of Latham & Watkins and a member of the Healthcare & Life Sciences Practice. He advises clients on regulatory, compliance, and transactional matters involving the US Food and Drug Administration (FDA) and other federal health agencies, including the medical device, pharmaceutical, biotechnology, human cell and tissue product, food, dietary supplement, and cosmetic industries.
Mr. Olson advises clients along the total product life-cycle of FDA-regulated products, including, among others:
- Pre-market product development and testing
- FDA premarket submissions
- Product advertising and promotion
- Quality systems, policies and procedure
- Responding to FDA Warning Letters and Inspections
- Internal Quality Investigations
Within the transactional space, Mr. Olson advises on regulatory diligence and disclosure matters for public offerings, mergers and acquisitions, and private transactions.
Mr. Olson’s pro bono practice has included representing individuals seeking asylum, non-profit organizations advocating for victims of domestic violence and abuse, Medicaid disputes with D.C.’s Department of Health Care Finance, and landlord/tenant disputes within the District of Columbia.
Mr. Olson previously served as Regulatory Counsel in the Center for Devices and Radiological Health at the Food and Drug Administration.